Efficacy and safety of the combination of reduced duration prophylaxis followed by immuno-guided prophylaxis to prevent cytomegalovirus disease in lung transplant recipients (CYTOCOR STUDY): An open-label, randomised, non-inferiority clinical trial

JULIAN CARLOS DE LA TORRE CISNEROS2026-01-292026-01-29201910.1136/bmjopen-2019-0306482-s2.0-85070830473https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/30731Medicine (all)Efficacy and safety of the combination of reduced duration prophylaxis followed by immuno-guided prophylaxis to prevent cytomegalovirus disease in lung transplant recipients (CYTOCOR STUDY): An open-label, randomised, non-inferiority clinical trialresearch article